Yale Comprehensive Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520-8028.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Yale Comprehensive Cancer Center has participated in 78 clinical trials with 3 currently active.
Therapeutic areas: Colorectal Cancer, Beta-Thalassemia, Leukemia.
Sponsors: National Cancer Institute (NCI), Boston University, Children's Oncology Group.
Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Yale Comprehensive Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale Comprehensive Cancer Center has 78 clinical trials on record, with 3 currently active. Their work covers Colorectal Cancer, Beta-Thalassemia, Leukemia.
Yes — Yale Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.